Contact Us Youtube Facebook linkedin Twitter

Abbott Case Study Competition


This competition is designed to acknowledge and reward case studies that address contemporary issues in the practice of diabetes care, diabetes education and self-management involving the use of flash blood glucose monitoring and ambulatory glucose profile.

ADEA members and healthcare professionals are encouraged to submit case studies and join the competition. The competition is managed and facilitated by ADEA, under consultation with a review panel of experienced endocrinologists and CDEs.

This program is financially supported by

Submission is Closed

Important dates


Entries can be submitted either in writing or verbally as a video.

Written case study

Maximum 600 words
Submissions to be sent via SurveyMonkey

Video case study

Maximum 6 minutes
Submission to be sent via SurveyMonkey

Topics for case study submissions

Submitted case studies included principles of person-centered care and adhere to the DA’s Language Position Statement while discussing the use of flash glucose monitoring1 with or without ambulatory glucose profile2 and addressing the following questions:

  1. How have the client’s outcomes (clinical or non-clinical) improved with this technology?
  2. How has the technology been used to make a difference to a client’s quality of life?
  3. How has the technology changed practice for an individual health professional or the diabetes care team?
  4. How has it helped to prevent an adverse event?
  5. What are the challenges clients have found with this technology? What has been done as a consequence?


  1. The flash glucose monitoring system utilises a glucose sensor/transmitter and handheld receiver to measure multiple glucose data points from interstitial fluid. The glucose sensor is worn on the arm continuously for 14 days and includes a transmitter to communicate with the handheld glucose device. The handheld glucose receiver is used to manually transfer the data and displays the current glucose level, trend arrow and history of the past 8 hours without the need for capillary glucose testing. The receiver may also be used with capillary blood as an insulin dose advisor, however, calibration with capillary blood is not required.
  2. The Ambulatory Glucose Profile is a software approach to collating and analysing glucose data. It combines glucose readings from multiple days/weeks of glucose monitoring into a single 24 hour period, featuring statistical information such as average, interquartile and interdecile ranges.

Selection Process

Round 1

Selected by reviewing panel

  1. Submitted case studies are reviewed to select top 10 winning case studies.
    a. 5 winning written case studies will be published in print (more details TBC)
    b. 5 winning video case studies will be available via ADEA website
  2. Among these 10, authors of the top 4 will be invited to present their case studies at the Australasian Diabetes Congress.

Round 2

Selected by delegates at the ADS-ADEA Annual Scientific Meeting for the People’s Choice Award

  1. Top 4 will be invited to present and discuss their case studies orally at the Australasian Diabetes Congress (10 minute presentation + 2 minute Q&A)
  2. Delegates will vote for their favourite presentation to find one recipient for the People’s Choice Award for the Best Case Study.
  3. Recipient of People’s Choice Award for the Best Case Study will be announced at the Award Ceremony during the Congress.

Prize structure

Top 10

People’s Choice Award

The ultimate award title acknowledging the best case study in the whole competition, selected by delegates at the ADC after the oral presentation and Q&A of the submitted case studies. Only the top 4 are eligible to be considered for this award.

Reviewing panel

  1. Rachel Freeman: Professional Services Manager
  2. Jenny Carmuciano: Person with type 1 diabetes
  3. Dr Sue-Lynn Lau: Endocrinologist at Westmead Hospital
  4. Peta Tauchmann: Chair of the ADEA Clinical Practice Committee
  5. Ann Bush: ADEA Board Member
  6. Tracey Tellam: ADEA Board Member
  7. Karen Crawford: Chair of ADEA Course Accreditation and Standards of Practice
  8. Dr Ashley Ng: Chair of the Twitter Champion Group

Consent process

Applicants must obtain written consent of people with diabetes discussed in the submitted case studies, giving permission that they are happy for the selected case studies to be published via print and/or online by ADEA.

Terms and conditions

  1. Submitted case studies must include any principle(s) of person-centred care and adhere to Diabetes Australia’s Language Position Statements while discussing one of the identified questions.
  2. Both written and video case studies must be completed via SurveyMonkey by the due date.
  3. Parts of the submitted case studies that are over the limit (i.e. from the 601st word of the written case study, or from the 7th minute of video case study) will not be considered.
  4. Submitted case studies must de-identify details of the person in the case study to ensure confidentiality. This means neither names nor initials, locations mentioned in the submissions, e.g. ‘a 32-year-old woman with newly diagnosed type 1 diabetes attended our health service for …’.
  5. Applicants must obtain consent of people with diabetes discussed in the submitted case studies, giving permission that they are happy for the selected case studies to be published via print and/or online by ADEA. Submitted case study without a matching consent will not be reviewed.
  6. Submitted case studies must follow Vancouver referencing style.
  7. 10 successful applicants will receive registrations to the 2019 ADC, financially supported by Abbott Diabetes Care. This prize in non-transferable or redeemable for cash.
  8. 10 successful case studies will be displayed at the Abbott Diabetes Care exhibition stand during the ADC.
  9. Recipient of the People’s Choice Award might have their case study published in ADE December.
  10. Members of the Reviewing Panel and members of the Abbott Libre Advisory Committee are not eligible for this competition.
  11. Any adverse events experienced by health professionals or people with diabetes should be reported through to Abbott Diabetes Care’s customer service.